de.mpg.escidoc.pubman.appbase.FacesBean
English
 
Help Guide Disclaimer Contact us Login
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Talk

Tools for the Glycome Analysis in the Post-Genomic Era

MPS-Authors
http://pubman.mpdl.mpg.de/cone/persons/resource/persons86442

Rapp,  E.
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons86321

Hennig,  R.
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons96173

Borowiak,  M.
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons86372

Kottler,  R.
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons86448

Reichl,  U.
Otto-von-Guericke-Universität Magdeburg;
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

Locator
There are no locators available
Fulltext (public)
There are no public fulltexts available
Supplementary Material (public)
There is no public supplementary material available
Citation

Rapp, E., Hennig, R., Borowiak, M., Kottler, R., & Reichl, U. (2011). Tools for the Glycome Analysis in the Post-Genomic Era. Talk presented at 7th ISABS Conference in Forensic, Anthropologic and Medical Genetics and Mayo Clinic Lectures in Translational Medicine. Bol, Island of Brač, Croatia. 2011-05-20 - 2011-05-24.


Cite as: http://hdl.handle.net/11858/00-001M-0000-0013-A69B-E
Abstract
Glycosylation is a post-translational modification that enriches protein complexity and function. Dysregulation of glycosylation is associated with a wide range of diseases, including cancer, diabetes, as well as congenital, cardiovascular, immunological and infectious disorders. With regard to biotechnology, proper glycosylation of biologicals is important, as deviations in glycosylation are known to be associated with adverse drug reactions and reduced therapeutic efficacy. Therefore, glycomics is a rapidly emerging field that can be viewed as a complement to other „omics“ approaches including proteomics and genomics. There is a dramatic dynamic increase in the demand for sophisticated databases and analytical tools in glycobiology respectively glycobiotechnology. However, glycomics is significantly lagging behind genomics and proteomics, mainly due to the absence of high-throughput analytical methods which can reliably quantify a multitude of glycan structures in complex biological samples. For that reason, the EU-wide collaborative project “Methods for high-throughput (HTP) analysis of protein glycosylation” is funded within the FP7 of the European Union and will be started in 2011. The project is designed to fill that technology gap through development of relevant, reliable, and affordable commercial HTP glycoanalysis tools. This modular glycoprofiling system – to be developed and established within the project – is based on three orthogonal analysis platforms (UPLC, MS and CGE-LIF). Project and analysis platforms will be presented, focussing on the glycoanalysis approach, based on multiplexed capillary gel electrophoresis with laser induced fluorescence detection (CGE-LIF) utilizing a DNA-sequencer, which shows high potential for high-throughput (HTP) glycoprofiling of glycoconjugates.